151 related articles for article (PubMed ID: 30411815)
1. Serine hydroxymethyltransferase 1 promoter hypermethylation increases the risk of essential hypertension.
Xu G; Wang C; Ying X; Kong F; Ji H; Zhao J; Zhang X; Duan S; Han L; Li L
J Clin Lab Anal; 2019 Mar; 33(3):e22712. PubMed ID: 30411815
[TBL] [Abstract][Full Text] [Related]
2. MTHFD1 promoter hypermethylation increases the risk of hypertension.
Xu M; Li J; Chen X; Han L; Li L; Liu Y
Clin Exp Hypertens; 2019; 41(5):422-427. PubMed ID: 30183434
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: a matched case-control study.
Mao SQ; Sun JH; Gu TL; Zhu FB; Yin FY; Zhang LN
J Hum Hypertens; 2017 Aug; 31(8):530-536. PubMed ID: 28300071
[TBL] [Abstract][Full Text] [Related]
4. Association between cytosolic serine hydroxymethyltransferase (SHMT1) gene polymorphism and cancer risk: a meta-analysis.
Wang Q; Lu K; Du H; Zhang Q; Chen T; Shu Y; Hua Y; Zhu L
Biomed Pharmacother; 2014 Jul; 68(6):757-62. PubMed ID: 25194438
[TBL] [Abstract][Full Text] [Related]
5. The association between serine hydroxymethyl transferase 1 gene hypermethylation and ischemic stroke.
Wang J; Gu J; Huang Y; Fang Y; Lin J
Bosn J Basic Med Sci; 2021 Aug; 21(4):454-460. PubMed ID: 33259775
[TBL] [Abstract][Full Text] [Related]
6. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension.
Fan R; Mao SQ; Gu TL; Zhong FD; Gong ML; Hao LM; Yin FY; Dong CZ; Zhang LN
Mol Med Rep; 2017 Jun; 15(6):3905-3911. PubMed ID: 28440441
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation of the Toll-like receptor-2 gene increases the risk of essential hypertension.
Mao S; Gu T; Zhong F; Fan R; Zhu F; Ren P; Yin F; Zhang L
Mol Med Rep; 2017 Jul; 16(1):964-970. PubMed ID: 28560381
[TBL] [Abstract][Full Text] [Related]
8. Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization.
Hebbring SJ; Chai Y; Ji Y; Abo RP; Jenkins GD; Fridley B; Zhang J; Eckloff BW; Wieben ED; Weinshilboum RM
J Neurochem; 2012 Mar; 120(6):881-90. PubMed ID: 22220685
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of the Interferon γ Gene as a Potential Risk Factor for Essential Hypertension: A Case-Control Study.
Bao XJ; Mao SQ; Gu TL; Zheng SY; Zhao JS; Zhang LN
Tohoku J Exp Med; 2018 Apr; 244(4):283-290. PubMed ID: 29643275
[TBL] [Abstract][Full Text] [Related]
10. SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.
Komlósi V; Hitre E; Pap E; Adleff V; Réti A; Székely E; Bíró A; Rudnai P; Schoket B; Müller J; Tóth B; Ottó S; Kásler M; Kralovánszky J; Budai B
BMC Cancer; 2010 Oct; 10():525. PubMed ID: 20920350
[TBL] [Abstract][Full Text] [Related]
11. DNMT3B C46359T and SHMT1 C1420T polymorphisms in the folate pathway in carcinogenesis of head and neck.
Succi M; de Castro TB; Galbiatti AL; Arantes LM; da Silva JN; Maniglia JV; Raposo LS; Pavarino EC; Goloni-Bertollo EM
Mol Biol Rep; 2014 Feb; 41(2):581-9. PubMed ID: 24362509
[TBL] [Abstract][Full Text] [Related]
12. A potential regulatory single nucleotide polymorphism in the promoter of the Klotho gene may be associated with essential hypertension in the Chinese Han population.
Wang HL; Xu Q; Wang Z; Zhang YH; Si LY; Li XJ; Yang QH; Xiao H
Clin Chim Acta; 2010 Mar; 411(5-6):386-90. PubMed ID: 20005218
[TBL] [Abstract][Full Text] [Related]
13. CBS promoter hypermethylation increases the risk of hypertension and stroke.
Wang C; Xu G; Wen Q; Peng X; Chen H; Zhang J; Xu S; Zhang C; Zhang M; Ma J; Hui Z; Wu G; Ma M
Clinics (Sao Paulo); 2019 Mar; 74():e630. PubMed ID: 30916171
[TBL] [Abstract][Full Text] [Related]
14. Association of AGTR1 Promoter Methylation Levels with Essential Hypertension Risk: A Matched Case-Control Study.
Fan R; Mao S; Zhong F; Gong M; Yin F; Hao L; Zhang L
Cytogenet Genome Res; 2015; 147(2-3):95-102. PubMed ID: 26658476
[TBL] [Abstract][Full Text] [Related]
15. Association of SHMT1 gene polymorphisms with the risk of childhood acute lymphoblastic leukemia in a sample of Iranian population.
Bahari G; Hashemi M; Naderi M; Sadeghi-Bojd S; Taheri M
Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):45-51. PubMed ID: 26950450
[TBL] [Abstract][Full Text] [Related]
16. SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients.
Wang YW; Zhang SD; Xue WJ; Zhu ML; Zheng LZ
Chin J Cancer; 2015 Dec; 34(12):573-82. PubMed ID: 26666829
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive association analysis between homocysteine metabolic pathway gene methylation and ischemic stroke in a Chinese hypertensive population.
Li B; Li Y; Xu S; Chen H; Dai S; Peng X; Wang L; Liang Y; Li C; Tang B; Zhu L; Zhang T; Lv C; Wang C; Han L
J Clin Lab Anal; 2021 Mar; 35(3):e23689. PubMed ID: 33382484
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia.
Skibola CF; Smith MT; Hubbard A; Shane B; Roberts AC; Law GR; Rollinson S; Roman E; Cartwright RA; Morgan GJ
Blood; 2002 May; 99(10):3786-91. PubMed ID: 11986237
[TBL] [Abstract][Full Text] [Related]
19. Significant association between DHFR promoter methylation and ischemic stroke in a Chinese hypertensive population.
Hu J; Zhu H; Xu G; Chen Z; Li L; Wang S; Deng H; Bao X; Shen Z
J Clin Lab Anal; 2020 Aug; 34(8):e23322. PubMed ID: 32319147
[TBL] [Abstract][Full Text] [Related]
20. α-Adducin gene promoter DNA methylation and the risk of essential hypertension.
Bayoumy NMK; El-Shabrawi MM; Leheta OF; Omar HH
Clin Exp Hypertens; 2017; 39(8):764-768. PubMed ID: 28686109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
